PROFESSIONAL EDITION

The largest community of pharma leaders

Look Who’s On the Move!

Yumanity Therapeutics Appoints Richard Peters, M.D., Ph.D., as Chief Executive Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Yumanity Therapeutics, a company focused on discovering and developing transformative therapies to treat neurodegenerative diseases, today announced the appointment of accomplished physician,...

Ocular Therapeutix™ Announces Patricia Kitchen as Chief Operations Officer

BEDFORD, Mass.--(BUSINESS WIRE)--$OCUL #OCUTX--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and...

Cutera Announces Appointment of David Mowry as Chief Executive Officer

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that...

Cell BT (CBI) Announces Appointment of Joshua Ofman, M.D., MSHS, to Board of Directors

LOS ANGELES--(BUSINESS WIRE)--Biotech/health policy pro Joshua Ofman MD signs on to board of Cell BT (CBI), innovators of discovery/development of novel immuno-oncology therapies....         http://www.businesswire.com/news/home/20190709005279/en/Cell-BT-CBI-Announces-Appointment-Joshua-Ofman  

Deciphera Pharmaceuticals, Inc. Announces Appointment of Susan L. Kelley, M.D., to its Board of Directors

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the appointment of...

Recent Articles